The intestinal microbiome in spondyloarthritis

Tejpal Gill, Mark Asquith, James (Jim) Rosenbaum, Robert A. Colbert

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Purpose of review: Microbial dysbiosis in the gut is emerging as a common component in various inflammatory disorders including spondyloarthritis (SpA). The depth of this influence has begun to be realized with next-generation sequencing of the gut microbiome providing unbiased assessment of previously uncharted bacterial populations. Recent findings: Decreased numbers of Firmicutes, a major phyla of gut commensals, especially the species Faecalibacterium prausnitzii and Clostridium leptum have been found in various inflammatory disorders including SpA and inflammatory bowel disease (IBD), and could be an important link between SpA and gut inflammation. Multiple studies in ankylosing spondylitis, psoriatic arthritis, juvenile SpA, and animal models of SpA are revealing common bacterial associations among these diseases as well as IBD. Summary: We are beginning to appreciate the complex relationship between the gut microbiome and host immune regulation and dysregulation in health and disease. Potentially important differences have been revealed in SpA, but cause and effect relationships remain far from established. Many critical questions remain to be answered before we can apply new knowledge to improve therapeutics in SpA.

Original languageEnglish (US)
Pages (from-to)319-325
Number of pages7
JournalCurrent Opinion in Rheumatology
Volume27
Issue number4
DOIs
StatePublished - Aug 24 2015

Fingerprint

Inflammatory Bowel Diseases
Dysbiosis
Juvenile Arthritis
Clostridium
Ankylosing Spondylitis
Animal Models
Inflammation
Health
Population
Gastrointestinal Microbiome
Therapeutics
Faecalibacterium prausnitzii
Firmicutes

Keywords

  • Ankylosing spondylitis
  • Dysbiosis
  • HLA-B27
  • Inflammatory bowel disease
  • Microbiome

ASJC Scopus subject areas

  • Rheumatology

Cite this

The intestinal microbiome in spondyloarthritis. / Gill, Tejpal; Asquith, Mark; Rosenbaum, James (Jim); Colbert, Robert A.

In: Current Opinion in Rheumatology, Vol. 27, No. 4, 24.08.2015, p. 319-325.

Research output: Contribution to journalArticle

Gill, Tejpal ; Asquith, Mark ; Rosenbaum, James (Jim) ; Colbert, Robert A. / The intestinal microbiome in spondyloarthritis. In: Current Opinion in Rheumatology. 2015 ; Vol. 27, No. 4. pp. 319-325.
@article{8de94815370048c49edb3bfa81966c11,
title = "The intestinal microbiome in spondyloarthritis",
abstract = "Purpose of review: Microbial dysbiosis in the gut is emerging as a common component in various inflammatory disorders including spondyloarthritis (SpA). The depth of this influence has begun to be realized with next-generation sequencing of the gut microbiome providing unbiased assessment of previously uncharted bacterial populations. Recent findings: Decreased numbers of Firmicutes, a major phyla of gut commensals, especially the species Faecalibacterium prausnitzii and Clostridium leptum have been found in various inflammatory disorders including SpA and inflammatory bowel disease (IBD), and could be an important link between SpA and gut inflammation. Multiple studies in ankylosing spondylitis, psoriatic arthritis, juvenile SpA, and animal models of SpA are revealing common bacterial associations among these diseases as well as IBD. Summary: We are beginning to appreciate the complex relationship between the gut microbiome and host immune regulation and dysregulation in health and disease. Potentially important differences have been revealed in SpA, but cause and effect relationships remain far from established. Many critical questions remain to be answered before we can apply new knowledge to improve therapeutics in SpA.",
keywords = "Ankylosing spondylitis, Dysbiosis, HLA-B27, Inflammatory bowel disease, Microbiome",
author = "Tejpal Gill and Mark Asquith and Rosenbaum, {James (Jim)} and Colbert, {Robert A.}",
year = "2015",
month = "8",
day = "24",
doi = "10.1097/BOR.0000000000000187",
language = "English (US)",
volume = "27",
pages = "319--325",
journal = "Current Opinion in Rheumatology",
issn = "1040-8711",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The intestinal microbiome in spondyloarthritis

AU - Gill, Tejpal

AU - Asquith, Mark

AU - Rosenbaum, James (Jim)

AU - Colbert, Robert A.

PY - 2015/8/24

Y1 - 2015/8/24

N2 - Purpose of review: Microbial dysbiosis in the gut is emerging as a common component in various inflammatory disorders including spondyloarthritis (SpA). The depth of this influence has begun to be realized with next-generation sequencing of the gut microbiome providing unbiased assessment of previously uncharted bacterial populations. Recent findings: Decreased numbers of Firmicutes, a major phyla of gut commensals, especially the species Faecalibacterium prausnitzii and Clostridium leptum have been found in various inflammatory disorders including SpA and inflammatory bowel disease (IBD), and could be an important link between SpA and gut inflammation. Multiple studies in ankylosing spondylitis, psoriatic arthritis, juvenile SpA, and animal models of SpA are revealing common bacterial associations among these diseases as well as IBD. Summary: We are beginning to appreciate the complex relationship between the gut microbiome and host immune regulation and dysregulation in health and disease. Potentially important differences have been revealed in SpA, but cause and effect relationships remain far from established. Many critical questions remain to be answered before we can apply new knowledge to improve therapeutics in SpA.

AB - Purpose of review: Microbial dysbiosis in the gut is emerging as a common component in various inflammatory disorders including spondyloarthritis (SpA). The depth of this influence has begun to be realized with next-generation sequencing of the gut microbiome providing unbiased assessment of previously uncharted bacterial populations. Recent findings: Decreased numbers of Firmicutes, a major phyla of gut commensals, especially the species Faecalibacterium prausnitzii and Clostridium leptum have been found in various inflammatory disorders including SpA and inflammatory bowel disease (IBD), and could be an important link between SpA and gut inflammation. Multiple studies in ankylosing spondylitis, psoriatic arthritis, juvenile SpA, and animal models of SpA are revealing common bacterial associations among these diseases as well as IBD. Summary: We are beginning to appreciate the complex relationship between the gut microbiome and host immune regulation and dysregulation in health and disease. Potentially important differences have been revealed in SpA, but cause and effect relationships remain far from established. Many critical questions remain to be answered before we can apply new knowledge to improve therapeutics in SpA.

KW - Ankylosing spondylitis

KW - Dysbiosis

KW - HLA-B27

KW - Inflammatory bowel disease

KW - Microbiome

UR - http://www.scopus.com/inward/record.url?scp=84942595534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942595534&partnerID=8YFLogxK

U2 - 10.1097/BOR.0000000000000187

DO - 10.1097/BOR.0000000000000187

M3 - Article

C2 - 26002022

AN - SCOPUS:84942595534

VL - 27

SP - 319

EP - 325

JO - Current Opinion in Rheumatology

JF - Current Opinion in Rheumatology

SN - 1040-8711

IS - 4

ER -